Middle East & Africa Rheumatoid Arthritis Therapeutics Market Size & Outlook
Middle East & Africa rheumatoid arthritis therapeutics market, 2018-2030 (US$M)
Related Markets
MEA rheumatoid arthritis therapeutics market highlights
- The MEA rheumatoid arthritis therapeutics market generated a revenue of USD 576.8 million in 2023.
- The market is expected to grow at a CAGR of 4.7% from 2024 to 2030.
- In terms of segment, biopharmaceuticals was the largest revenue generating molecule in 2023.
- Biopharmaceuticals is the most lucrative molecule segment registering the fastest growth during the forecast period.
- Country-wise, UAE is expected to register the highest CAGR from 2024 to 2030.
MEA data book summary
| Market revenue in 2023 | USD 576.8 million |
| Market revenue in 2030 | USD 793.2 million |
| Growth rate | 4.7% (CAGR from 2023 to 2030) |
| Largest segment | Biopharmaceuticals |
| Fastest growing segment | Biopharmaceuticals |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pharmaceuticals, Biopharmaceuticals |
| Key market players worldwide | Boehringer Ingelheim, Novartis AG ADR, Regeneron Pharmaceuticals Inc, Pfizer Inc, Bristol-Myers Squibb Co, Roche Holding AG, UCB SA, Johnson & Johnson, Amgen Inc, AbbVie Inc |
Other key industry trends
- In terms of revenue, MEA region accounted for 2.3% of the global rheumatoid arthritis therapeutics market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 6,884.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Rheumatoid Arthritis Therapeutics Market Scope
Rheumatoid Arthritis Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Middle East & Africa rheumatoid arthritis therapeutics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to rheumatoid arthritis therapeutics market will help companies and investors design strategic landscapes.
Biopharmaceuticals was the largest segment with a revenue share of 88.66% in 2023. Horizon Databook has segmented the Middle East & Africa rheumatoid arthritis therapeutics market based on pharmaceuticals, biopharmaceuticals covering the revenue growth of each sub-segment from 2018 to 2030.
The Middle East & Africa (MEA) rheumatoid arthritis therapeutics market is undergoing significant developments, influenced by challenges and opportunities. Over the past year, there has been a shift in the region's pharmaceutical landscape, with governments in the Middle East emphasizing domestic pharmaceutical production to reduce dependency on imports.
Countries like the UAE and Egypt are emerging as pharmaceutical hubs, leveraging existing trade routes to capitalize on the growing demand for medicines, including treatments for conditions like RA. Despite these positive developments, the MEA region still faces regulatory and pricing challenges that need to be addressed to fully realize its pharmaceutical potential.
Regulatory frameworks must be streamlined to facilitate smoother market entry for new therapies, while pricing structures need to be balanced to ensure affordability without compromising the quality of care.
Reasons to subscribe to Middle East & Africa rheumatoid arthritis therapeutics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa rheumatoid arthritis therapeutics market databook
-
Our clientele includes a mix of rheumatoid arthritis therapeutics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa rheumatoid arthritis therapeutics market, including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa rheumatoid arthritis therapeutics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA rheumatoid arthritis therapeutics market size, by country, 2018-2030 (US$M)
Middle East & Africa Rheumatoid Arthritis Therapeutics Market Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
